Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/PROTALEX-INC-120787443/news/Protalex-Doses-First-Patient-in-Final-and-Highest-Dose-Cohort-of-European-Phase-1b-Study-of-PRTX-100-34850089/?utm_source=whatsapp&utm_medium=social&utm_campaign=share